Throughout 2025, drugmakers of all stripes have collectively poured billions of dollars into U.S. manufacturing investments.

New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharmaceutical API Manufacturing Global Market Report 2023" - https ...

The Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Market Size is projected to grow at a CAGR of 8.2% from ...

The global pharmaceutical contract manufacturing market is set to hit USD 311.95 billion by 2030, climbing from USD 209.90 ...

Industrial-scale continuous API manufacturing may offer cost and safety benefits. A growing number of companies around the world are using continuous processes to make small-molecule APIs. “There’s ...

Efficiency and adaptability are crucial in the ever-evolving manufacturing industry. As manufacturers adopt advanced technologies like IoT, AI, and cloud computing, the need for seamless integration ...

As quality issues have led to drug shortages, Donald Ashley, director of FDA’s Office of Compliance, raised several major concerns on Tuesday with the active pharmaceutical ingredient (API) industry, ...

Eight months after convincing five companies to pay fines to settle antitrust claims, the European Commission has zeroed in on another firm, active pharmaceutical ingredients (API) manufacturer Alchem ...

The US Food and Drug Administration (FDA) on Tuesday released a warning letter sent 27 June to China-based Zhuhai United Laboratories Co. for significant deviations from CGMP for active pharmaceutical ...

The agency issued a warning letter to Canadian API manufacturer, Les Produits Chimiques B.G.R, citing cGMP violations at its API facility in Pointe-Claire, Quebec. On July 24, 2018, FDA issued a ...